- Home
- CNTX vs RSSS Comparison
CNTX vs RSSS Comparison
Compare CNTX & RSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- RSSS
- Stock Information
- Founded
- CNTX 2015
- RSSS 2006
- Country
- CNTX United States
- RSSS United States
- Employees
- CNTX N/A
- RSSS N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- RSSS Business Services
- Sector
- CNTX Health Care
- RSSS Consumer Discretionary
- Exchange
- CNTX Nasdaq
- RSSS Nasdaq
- Market Cap
- CNTX 78.0M
- RSSS 90.6M
- IPO Year
- CNTX 2021
- RSSS N/A
- Fundamental
- Price
- CNTX $0.84
- RSSS $2.76
- Analyst Decision
- CNTX Strong Buy
- RSSS
- Analyst Count
- CNTX 5
- RSSS 0
- Target Price
- CNTX $5.50
- RSSS N/A
- AVG Volume (30 Days)
- CNTX 197.0K
- RSSS 35.8K
- Earning Date
- CNTX 08-06-2025
- RSSS 09-18-2025
- Dividend Yield
- CNTX N/A
- RSSS N/A
- EPS Growth
- CNTX N/A
- RSSS N/A
- EPS
- CNTX N/A
- RSSS N/A
- Revenue
- CNTX N/A
- RSSS $48,753,578.00
- Revenue This Year
- CNTX N/A
- RSSS $12.42
- Revenue Next Year
- CNTX N/A
- RSSS $7.47
- P/E Ratio
- CNTX N/A
- RSSS N/A
- Revenue Growth
- CNTX N/A
- RSSS 14.85
- 52 Week Low
- CNTX $0.49
- RSSS $2.32
- 52 Week High
- CNTX $2.75
- RSSS $4.24
- Technical
- Relative Strength Index (RSI)
- CNTX 64.84
- RSSS 45.92
- Support Level
- CNTX $0.82
- RSSS $2.66
- Resistance Level
- CNTX $0.87
- RSSS $2.92
- Average True Range (ATR)
- CNTX 0.07
- RSSS 0.12
- MACD
- CNTX 0.01
- RSSS -0.01
- Stochastic Oscillator
- CNTX 58.27
- RSSS 53.12
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.